Results 111 to 120 of about 806,245 (216)

Extravascular factor IX after gene therapy in hemophilia B, does it matter?

open access: yesResearch and Practice in Thrombosis and Haemostasis
Gene therapy will very likely change the treatment paradigm of hemophilia B in the coming years. For the majority of patients, adjunctive exogenous factor (F)IX clotting factor concentrate will continue to be needed in case of surgery or bleeding ...
Quentin Van Thillo, Cédric Hermans
doaj  

Genetic variability: The key problem in the prevention and therapy of RNA‐based virus infections [PDF]

open access: bronze, 2003
Magdalena Figlerowicz   +3 more
openalex   +1 more source

Chronic Myeloid Leukemia Following Therapy With Imatinib Mesylate (Gleevec): Bone Marrow Histopathology and Correlation With Genetic Status [PDF]

open access: bronze, 2003
Debra Resta   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy